1 – 100 of 210
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
(
- Contribution to journal › Article
-
Mark
Cardiovascular disease risk in early rheumatoid arthritis : the impact of cartilage oligomeric matrix protein (COMP) and disease activity
(
- Contribution to journal › Article
- 2022
-
Mark
VEXAS : Medicinhistorisk kommentar apropå inslaget "UR VARDAGEN" i Reumabulletinen 151, 1/2022
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2021
-
Mark
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy : A Swedish Nationwide Register Study
(
- Contribution to journal › Article
- 2020
-
Mark
Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden
(
- Contribution to journal › Article
-
Mark
Reumatologi? Nej tack, men man kan ju ändra sig!
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2019
-
Mark
Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis
(
- Contribution to journal › Article
- 2017
-
Mark
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
(
- Contribution to journal › Article
-
Mark
Activation of complement by pigment epithelium-derived factor in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Indelning av de reumatiska sjukdomarna
2017) p.41-47(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Differentialdiagnostik vid ledsymtom
2017) p.91-97(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Vad är reumatologi?
2017) p.21-24(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Rituximab in clinical practice : dosage, drug adherence, Ig levels, infections, and drug antibodies
(
- Contribution to journal › Article
-
Mark
Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays
(
- Contribution to journal › Article
-
Mark
Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies
(
- Contribution to journal › Article
- 2016
-
Mark
Diet induced arthritis in pigs: Comment on the Article by Scher et al.
(
- Contribution to journal › Letter
-
Mark
Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
(
- Contribution to journal › Article
-
Mark
Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective
(
- Contribution to journal › Article
-
Mark
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
(
- Contribution to journal › Article
-
Mark
Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal : A Prospective Observational Cohort Study from Southern Sweden
(
- Contribution to journal › Article
-
Mark
Metotrexat - Cellgiftet som blev basterapi vid reumatoid artrit
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2015
-
Mark
Development of functional impairment and disability in rheumatoid arthritis patients followed for 20 years - relation to disease activity, joint damage and comorbidity.
(
- Contribution to journal › Article
-
Mark
The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients.
(
- Contribution to journal › Article
-
Mark
Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab.
(
- Contribution to journal › Letter
-
Mark
Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.
(
- Contribution to journal › Article
-
Mark
The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
(
- Contribution to journal › Article
- 2014
-
Mark
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
(
- Contribution to journal › Article
-
Mark
Is Swollen to Tender Joint Count Ratio a New and Useful Clinical Marker for Biologic Drug Response in Rheumatoid Arthritis? Results From a Swedish Cohort
(
- Contribution to journal › Article
-
Mark
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria.
(
- Contribution to journal › Article
-
Mark
Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis - a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Novel COMP Neoepitopes Identified in Synovial Fluids from Patients with Joint Diseases using Affinity Chromatography and Mass Spectrometry.
(
- Contribution to journal › Article
-
Mark
Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjogren's syndrome and rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Articular cartilage
2014) p.33-41(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis
(
- Contribution to journal › Article
-
Mark
Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs
(
- Contribution to journal › Article
-
Mark
COMP-C3b Complexes in Rheumatoid Arthritis with Severe Extraarticular Manifestations.
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Reumatologisk forskning i Lund/Malmö
(
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Tema: Ledord. Ortopedi. Reumatologi. Förord
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2012
-
Mark
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-alpha treatment
(
- Contribution to journal › Article
-
Mark
Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohorts
(
- Contribution to journal › Letter
-
Mark
Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study
(
- Contribution to journal › Article
-
Mark
Interactions of the complement system with molecules of extracellular matrix: Relevance for joint diseases.
(
- Contribution to journal › Article
-
Mark
Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascade .
(
- Contribution to journal › Article
-
Mark
PRELP Protein Inhibits the Formation of the Complement Membrane Attack Complex
(
- Contribution to journal › Article
-
Mark
Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease.
(
- Contribution to journal › Article
-
Mark
Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis.
(
- Contribution to journal › Article
- 2011
-
Mark
Delays in assessment of patients with rheumatoid arthritis: variations across Europe
(
- Contribution to journal › Article
-
Mark
S100A8/A9 in bleomycin-induced skin fibrosis
2011) 31st European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 70(Suppl. 2).(
- Contribution to journal › Published meeting abstract
-
Mark
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
(
- Contribution to journal › Article
-
Mark
Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
(
- Contribution to journal › Article
-
Mark
Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
(
- Contribution to journal › Article
-
Mark
Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.
(
- Contribution to journal › Article
-
Mark
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis.
(
- Contribution to journal › Article
-
Mark
The role of the cartilage matrix in osteoarthritis.
(
- Contribution to journal › Article
-
Mark
The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trials.
(
- Contribution to journal › Article
-
Mark
Ten years with biologics: to whom do data on effectiveness and safety apply?
(
- Contribution to journal › Article
-
Mark
Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Differentialdiagnostik vid ledsymtom
2011) p.39-44(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Vad är reumatologi?
2011) p.15-17(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2010
-
Mark
Utility-based outcomes made easy: The number needed per QALY gained (NNQ). Observational cohort study from Southern Sweden of TNF blockade in inflammatory arthritis.
(
- Contribution to journal › Article
-
Mark
Rapid and sustained health utility gain in anti-TNF treated inflammatory arthritis. Observational data during seven years in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Presence of peripheral arthritis and male sex predicting continuation of anti–tumor necrosis factor therapy in ankylosing spondylitis: An observational prospective cohort study from the South Swedish arthritis treatment group register
(
- Contribution to journal › Article
-
Mark
Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training
(
- Contribution to journal › Article
-
Mark
Regulation of complement by COMP allows for a novel molecular diagnostic principle in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study.
(
- Contribution to journal › Article
- 2009
-
Mark
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
Natural course of knee osteoarthritis in middle-aged subjects with knee pain: 12-year follow-up using clinical and radiographic criteria
(
- Contribution to journal › Article
-
Mark
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor alpha Therapies Does the Risk Change With the Time Since Start of Treatment?
(
- Contribution to journal › Article
-
Mark
Association of Biomarkers With Pre-Radiographically Defined and Radiographically Defined Knee Osteoarthritis in a Population-Based Study
(
- Contribution to journal › Article
-
Mark
Dose escalation of infliximab therapy in arthritis patients is related to diagnosis and concomitant methotrexate treatment: observational results from the South Swedish Arthritis Treatment Group register.
(
- Contribution to journal › Article
-
Mark
Differences in Longitudinal Disease and Treatment Characteristics of Patients with Rheumatoid Arthritis Replying and Not Replying to a Postal Questionnaire. Experience from a Biologics Register in Southern Sweden.
(
- Contribution to journal › Article
-
Mark
Bone mineral density in the hand as a predictor for mortality in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
- 2008
-
Mark
Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement
(
- Contribution to journal › Article
-
Mark
Biomarkers in the prediction of radiographic progression in early rheumatoid arthritis: comment on the article by Young-Min et al - Reply
(
- Contribution to journal › Letter
-
Mark
Increased serum levels of cartilage oligomeric matrix protein precede the clinical onset of rheumatoid arthritis despite lower levels among smokers
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.289-290(
- Contribution to journal › Published meeting abstract
-
Mark
Health utilities improvement during TNF blockade in chronic arthritis occurs early in the treatment course, results from an eight year observational study in southern Sweden
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.552-552(
- Contribution to journal › Published meeting abstract
-
Mark
The Swedish biologics register (ARTIS): observations of adverse events when using biologics in clinical practice
(
- Contribution to journal › Published meeting abstract
-
Mark
Citrullinated proteins are present in synovial fluids from inflammatory arthritis but not osteoarthritis
(
- Contribution to journal › Published meeting abstract
-
Mark
Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis
(
- Contribution to journal › Article
-
Mark
COMP a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker
(
- Contribution to journal › Article
-
Mark
Efficacy and tolerability of anti-TNF therapy in psoriatic arthritis patients: Results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
- 2007
-
Mark
The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.
(
- Contribution to journal › Article
-
Mark
The impact of IL-1Ra and MBL gene polymorphisms on joint damage after 5 and 10 years in patients with early rheumatoid arthritis
(
- Contribution to journal › Letter
-
Mark
Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab
(
- Contribution to journal › Letter
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article